Yujuan Gao

4PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Cardiovascular medicine and haematology not elsewhere classifiedMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 07, 2025
Correction: Mortality Risk Prediction in Patients With Antimelanoma Differentiation-Associated, Gene 5 Antibody-Positive, Dermatomyositis-Associated Interstitial Lung Disease: Algorithm Development and Validation.

Hui Li, Ruyi Zou, Hongxia Xin

|Feb 05, 2025
Mortality Risk Prediction in Patients With Antimelanoma Differentiation-Associated, Gene 5 Antibody-Positive, Dermatomyositis-Associated Interstitial Lung Disease: Algorithm Development and Validation.

Hui Li, Ruyi Zou, Hongxia Xin

|Jun 18, 2020
Anti-PD-1 Therapy Achieved Disease Control After Multiline Chemotherapy in Unresectable KRAS-Positive Hepatoid Lung Adenocarcinoma: A Case Report and Literature Review.

Lulu Chen, Xue Han, Yujuan Gao

|Mar 03, 2019
SPOCK1 contributes to the third-generation EGFR tyrosine kinase inhibitors resistance in lung cancer.

Yujuan Gao, Min Yu, Miao Ma

Pageof 1

Frequent Collaborators

2 joint publications

Hui Li

2 joint publications

Ruyi Zou

2 joint publications

Hongxia Xin

2 joint publications

Ping He